Purpose To explore racial differences in the use and outcome of neoadjuvant chemotherapy
for breast cancer. Methods The National Cancer Data Base was queried to identify women …

Importance With the increasing delivery of neoadjuvant chemotherapy (NACT) for patients
with breast cancer in the US, it is important to know whether there is differential response to …

Previous studies demonstrated poor response to neoadjuvant systemic therapy (NST) for
breast cancer among black women and women who are overweight or obese, but this may …

Purpose There are a paucity of data and a pressing need to evaluate response to
neoadjuvant chemotherapy (NACT) and determine long-term outcomes in young Black …

BACKGROUND: Racial disparities in breast cancer outcomes are attributed to differences in
baseline tumour characteristics and biology, stage, age, ethnic background and …

The effect of race on breast cancer outcome is confounded by tumor and treatment
heterogeneity. We examined a cohort of women with stage II–III breast cancer treated …

Importance Among patients with breast cancer, inconsistent findings have been published
on racial disparities in achieving pathologic complete response (pCR) after neoadjuvant …

BACKGROUND: The current study was conducted to evaluate the influence of race/ethnicity
and tumor subtype in pathologic complete response (pCR) following treatment with …

While large differences by race/ethnicity in breast cancer survival are well established, it is
unknown whether differences in quality of chemotherapy delivered explain the racial/ethnic …

BACKGROUND Neoadjuvant chemotherapy (NAC) is the standard of care for patients with
locally advanced breast cancer and can yield clinical advantages in individuals with lower …